GerosMicro
Financial Marketplace
Investment & Growth Platform
Preparing your investment experience
Initializing platform... 00%
Clarity Pharmaceuticals Granted Breakthrough Therapy Designation for Prostate Cancer Copper Theranostic
  • smallcaps.com.au
  • Posted On 12 November 2026

Clarity Pharmaceuticals Granted Breakthrough Therapy Designation for Prostate Cancer Copper Theranostic

The US Food and Drug Adminstration has granted Clarity Pharmaceuticals (ASX: CU6) breakthrough therapy designation for 64Cu-SAR-bisPSMA used in positron emissio...
Source: smallcaps.com.au
Share Now

Live Support

We're here to help

CUSTOMER SUPPORT

Hello! How can we help you?

Send us a message and our Protocol Officer will assist you.

Connecting to support...